Revelation Biosciences, Inc. (REVB)
1.01
0.00 (0.00%)
USD |
NASDAQ |
Sep 09, 12:06
Revelation Biosciences Shareholders Equity (Quarterly) : 10.07M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 10.07M |
| March 31, 2026 | 12.99M |
| December 31, 2025 | 8.861M |
| September 30, 2025 | 11.00M |
| June 30, 2025 | 3.826M |
| March 31, 2025 | 2.881M |
| December 31, 2024 | 4.708M |
| September 30, 2024 | 2.674M |
| June 30, 2024 | 1.140M |
| March 31, 2024 | 9.473M |
| December 31, 2023 | 6.648M |
| September 30, 2023 | 8.818M |
| June 30, 2023 | 11.41M |
| March 31, 2023 | 10.02M |
| Date | Value |
|---|---|
| December 31, 2022 | 1.052M |
| September 30, 2022 | 2.228M |
| June 30, 2022 | -1.843M |
| March 31, 2022 | -0.0985M |
| December 31, 2021 | -0.0995M |
| September 30, 2021 | 66.91M |
| June 30, 2021 | 67.66M |
| March 31, 2021 | 69.00M |
| December 31, 2020 | 67.82M |
| September 30, 2020 | 0.0128M |
| June 30, 2020 | 0.0137M |
| March 31, 2020 | |
| December 31, 2019 | -0.0036M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Shuttle Pharmaceuticals Holdings, Inc. | 3.346M |
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Agenus, Inc. | -199.08M |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Amgen, Inc. | 11.69B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 12.50M |
| Total Liabilities (Quarterly) | 2.431M |
| Debt to Equity Ratio | 0.0735 |
| Current Ratio | 6.214 |
| Net Debt Paydown Yield | -3.68% |